Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (41 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 08 Mar 2016 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 100 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | PGIM India Large Cap Fund |
|---|---|
| 08 Mar 2016 | ₹100.00 |
| 20 Jan 2017 | ₹98.87 |
| 04 Dec 2017 | ₹107.43 |
| 18 Oct 2018 | ₹90.47 |
| 01 Sep 2019 | ₹87.29 |
| 15 Jul 2020 | ₹78.50 |
| 30 May 2021 | ₹107.77 |
| 13 Apr 2022 | ₹105.16 |
| 25 Feb 2023 | ₹101.36 |
| 09 Jan 2024 | ₹113.56 |
| 22 Nov 2024 | ₹116.62 |
| 06 Oct 2025 | ₹112.99 |
| 20 Aug 2026 | ₹104.25 |
| Metric | PGIM India · Regular · IDCW NAV ₹18.38 Very High risk ★☆☆☆☆ | Category median Large Cap Fund · 41 funds |
|---|---|---|
| -10.12% | -5.49% | |
| -1.17% | +7.73% | |
| -1.52% | +6.21% | |
| -0.46% | +4.02% | |
| +0.40% | +5.54% | |
| -2.13% | — | |
| +1.48% | +6.92% | |
| +2.52% | +6.12% | |
| -0.13% | +3.99% | |
| Risk | ||
| 13.83% | 14.74% | |
| -0.55 | 0.02 | |
| -0.72 | 0.03 | |
| -49.40% | -48.01% | |
| Nifty 100 | — | |
| -10.31% | -1.74% | |
| 0.95 | 0.98 | |
| 62.5% | 93.8% | |
| 112.5% | 102.3% | |
| 2.61% | 2.38% | |
| ₹538.67Cr | ₹1,495Cr | |
| Up to 0.50% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 151% | 58% | |
| Padmanabhan Anjeneyan | — | |
| 08 Mar 2016 | — | |
| 58 | — | |
| 45.2% | — | |
| 0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.